@article{10902/28386,
year = {2023},
month = {2},
url = {https://hdl.handle.net/10902/28386},
abstract = {Pain symptoms after the acute phase of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are present in almost 50% of COVID-19 survivors. The presence of kinesiophobia is a risk factor which may promote and perpetuate pain. This study aimed to investigate variables associated with the presence of kinesiophobia in a sample of previously hospitalized COVID-19 survivors exhibiting post-COVID pain. An observational study was conducted in three urban hospitals in Spain, including one hundred and forty-six COVID-19 survivors with post-COVID pain. Demographic (age, weight, height), clinical (intensity and duration of pain), psychological (anxiety level, depressive level, sleep quality), cognitive (catastrophizing), sensitization-associated symptoms, and health-related quality of life variables were collected in 146 survivors with post-COVID pain, as well as whether they exhibited kinesiophobia. Stepwise multiple linear regression models were  conducted to identify variables significantly associated with kinesiophobia. Patients were assessed a mean of 18.8 (SD 1.8) months after hospital discharge. Kinesiophobia levels were positively associated with anxiety levels (r: 0.356, p < 0.001), depression levels (r: 0.306, p < 0.001), sleep quality (r: 0.288, p < 0.001), catastrophism (r: 0.578, p < 0.001), and sensitization-associated symptoms (r: 0.450, p < 0.001). The stepwise regression analysis revealed that 38.1% of kinesiophobia variance was explained by catastrophism (r² adj: 0.329, B = 0.416, t = 8.377, p < 0.001) and sensitization-associated symptoms (r² adj: 0.381, B = 0.130, t = 3.585, p < 0.001). Kinesiophobia levels were associated with catastrophism and sensitization-associated symptoms in previously hospitalized COVID-19 survivors with post-COVID pain. Identification of patients at a higher risk of developing a higher level of kinesiophobia, associated with post-COVID pain symptoms, could lead to better therapeutic strategies.},
organization = {Funding: The project was supported by a grant of Comunidad de Madrid y la Unión Europea, a
través del Fondo Europeo de Desarrollo Regional (FEDER), Recursos REACT-UE del Programa
Operativo de Madrid 2014–2020, financiado como parte de la respuesta de la Unión a la pandemia de
COVID-19 (LONG-COVID-EXP-CM), by a grant from Next-Val 2021 de la Fundación Instituto de
Investigación Marqués de Valdecilla (IDIVAL), and by a grant from the Novo Nordisk Foundation
0067235. The sponsors had no role in the design, collection, management, analysis, or interpretation
of the data, draft, review, or approval of the manuscript or its content. The authors were responsible for the decision to submit the manuscript for publication, and the sponsor did not participate in this decision.},
publisher = {MDPI},
publisher = {Diagnostics 2023, 13(5), 847},
title = {Association of kinesiophobia with catastrophism and sensitization-associated symptoms in COVID-19 survivors with post-COVID pain},
author = {Herrero Montes, Manuel and Férnandez de las Peás, César and Ferrer Pargada, Diego and Izquierdo Cuervo, Sheila and Abascal Bolado, Beatriz and Valera Calero, Juan Antonio and Parás Bravo, Paula},
}